Nu Skin Enterprises Given Consensus Recommendation of “Hold” by Analysts (NYSE:NUS)
Shares of Nu Skin Enterprises (NYSE:NUS) have received a consensus recommendation of “Hold” from the ten ratings firms that are covering the company, ARN reports. Three analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $76.78.
Nu Skin Enterprises (NYSE:NUS) opened at 44.72 on Thursday. Nu Skin Enterprises has a 52 week low of $43.50 and a 52 week high of $140.50. The stock’s 50-day moving average is $55.68 and its 200-day moving average is $72.57. The company has a market cap of $2.649 billion and a price-to-earnings ratio of 8.96.
Nu Skin Enterprises (NYSE:NUS) last released its earnings data on Wednesday, August 6th. The company reported $1.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.27 by $0.14. The company had revenue of $650.00 million for the quarter, compared to the consensus estimate of $709.03 million. During the same quarter in the previous year, the company posted $1.22 earnings per share. The company’s revenue for the quarter was down 3.1% on a year-over-year basis. On average, analysts predict that Nu Skin Enterprises will post $4.13 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, September 26th. Stockholders of record on Friday, September 12th will be given a dividend of $0.345 per share. This represents a $1.38 dividend on an annualized basis and a yield of 3.09%. The ex-dividend date of this dividend is Wednesday, September 10th.
A number of analysts have recently weighed in on NUS shares. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Nu Skin Enterprises in a research note on Thursday, August 7th. They now have a $70.00 price target on the stock, down previously from $110.00. Separately, analysts at Canaccord Genuity reiterated a “hold” rating on shares of Nu Skin Enterprises in a research note on Thursday, August 7th. They now have a $53.00 price target on the stock, down previously from $92.00. Finally, analysts at JPMorgan Chase & Co. downgraded shares of Nu Skin Enterprises from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 7th. They now have a $50.00 price target on the stock, down previously from $100.00.
Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.